Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Johnsen

Showing results (171-180 of 203) with videos related to

Pageof 21
Sort By:
Journal of the National Cancer Institute|February 10, 2016
Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic CancerMarkus A Schirmer, Claudia M Lüske, Sebastian Roppel, et al.
Genes & Development|October 4, 2008
The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expressionEfrat Shema, Itay Tirosh, Yael Aylon, et al.
International Journal of Cancer|June 30, 2020
Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinomaXin Zhang, Tim Zegar, Tim Weiser, et al.
Cancer Gene Therapy|January 8, 2021
CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivoSu Jung Oh-Hohenhorst, Derya Tilki, Ann-Kristin Ahlers, et al.
Cancer Research|September 10, 2020
EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of <i>GATA6</i>Shilpa Patil, Benjamin Steuber, Waltraut Kopp, et al.
Acta Physiologica (Oxford, England)|September 28, 2019
Novel role of Tieg1 in muscle metabolism and mitochondrial oxidative capacitiesMalek Kammoun, Jerome Piquereau, Lydie Nadal-Desbarats, et al.
Gut|January 13, 2017
Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancerE Hessmann, M S Patzak, L Klein, et al.
Cell Death and Differentiation|June 5, 2021
RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel diseaseRobyn Laura Kosinsky, Maria Zerche, Ana Patricia Kutschat, et al.
Neuro-Oncology|April 9, 2022
STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline gliomaLiang Zhang, Cody L Nesvick, Charlie A Day, et al.
Clinical Epigenetics|January 16, 2024
Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylationLaura K Godfrey, Jan Forster, Sven-Thorsten Liffers, et al.
Pageof 21

Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
Journal of the National Cancer Institute|February 10, 2016
Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic CancerMarkus A Schirmer, Claudia M Lüske, Sebastian Roppel, et al.
Genes & Development|October 4, 2008
The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expressionEfrat Shema, Itay Tirosh, Yael Aylon, et al.
International Journal of Cancer|June 30, 2020
Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinomaXin Zhang, Tim Zegar, Tim Weiser, et al.
Cancer Gene Therapy|January 8, 2021
CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivoSu Jung Oh-Hohenhorst, Derya Tilki, Ann-Kristin Ahlers, et al.
Cancer Research|September 10, 2020
EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of <i>GATA6</i>Shilpa Patil, Benjamin Steuber, Waltraut Kopp, et al.
Acta Physiologica (Oxford, England)|September 28, 2019
Novel role of Tieg1 in muscle metabolism and mitochondrial oxidative capacitiesMalek Kammoun, Jerome Piquereau, Lydie Nadal-Desbarats, et al.
Gut|January 13, 2017
Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancerE Hessmann, M S Patzak, L Klein, et al.
Cell Death and Differentiation|June 5, 2021
RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel diseaseRobyn Laura Kosinsky, Maria Zerche, Ana Patricia Kutschat, et al.
Neuro-Oncology|April 9, 2022
STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline gliomaLiang Zhang, Cody L Nesvick, Charlie A Day, et al.
Clinical Epigenetics|January 16, 2024
Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylationLaura K Godfrey, Jan Forster, Sven-Thorsten Liffers, et al.
Pageof 21